Abstract
Alpha-1-proteinase inhibitor activity was studied in presence of resting and activated polymorphonuclear leucocytes. Four different agonists; phorbol myristic acetate, N-formyl-methionyl-leucyl-phenylalanine, opsonised zymosan and arachidonic acid decreased the inhibitor activity by 23.3%, 20%, 12% and 16.6^ respectively. The inhibitor activity was protected by using various free radical scavengers. Catalase and superoxide dismutase both restored activity by about 18%, mannitol by 13% and sodium azide by 17.3%. The inhibitor activity was also protected significantly by pretreatment of polymorphs with L-Arg, a precursor of nitric oxide, before activation. L-Arg was also observed to suppress the generation of superoxide and hydroxyl radical appreciably. The nitric oxide synthase inhibitor, aminoguanidine drastically inhibited the nitrite release and reversed the protection offered by L-Arg to the inhibitor activity. Our results indicate a multifactorial nature of the inactivation process, the culprit species being superoxide, hydrogen peroxide, hydroxyl radical and hypohalides. Nitric oxide seems to scavenge the superoxide radical directly after its formation rather than inhibiting its generation by NADPH oxidase as was believed earlier.
Similar content being viewed by others
References
Malech, H. L., Gallin, M. D. (1987) Neutrophils in human disease. N. Engl. J. Med. 317, 687–694.
Geiszt, M. and Leto, T.L. (2004) The Nox family of NAD(P)H oxidase: host defence and beyond. J. Biol. Chem. 279, 51715–51718.
Quinn, M.T. and Gauss, K.A. (2004) Structure and regulation of the neutrophil respiratory burst: comparison with non-phagocyte oxidases. J. Leukoc. Biol. 76, 760–781.
Smith, J.A. (1994) Neutrophils, host defense and inflammation: a double-edged sword. J. Leukoc. Biol. 56, 672–686.
Sethi, S., Sing, M.P. and Dikshit, M. (1999) Nitric oxide- mediated augmentation of polymorphonuclear free radical generation after hypoxia-reoxygenation. Blood 93, 333–340.
Carreras, M. C., Pargament, G. A., Catz, S. D., Poderoso, J. J. and Boveris, A. (1994) Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 341, 65–71.
Beckman, J.S., Chen, J., Ischiropoulos, H. and Crow, J.P. (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol. 233, 229–240.
Moreno-Manzano, V., Ishikawa, Y. and Lucio-Cazana J. (2000) Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumour necrosis factor-á-induced apoptosis of rat mesangial cells. J. Biol. Chem. 25, 12684–12691.
Suzuki, Y.J., Forman, H.J., and Sevanian, A. (1997) Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22, 269–285.
Rabadji, R.C., Brigagao, M.R.P.L., Camerero, V.C.P.C. and Colepicolo, P. (1996) Oscillation of reactive oxygen species released by activated neutrophils. Biological Rhythm Research 27, 269–280.
Salvemini, D., Ischiropoulos, H. and Cuzzocrea, S. (2003) Roles of nitric oxide and superoxide in inflammation. Methods Mol. Biol. 225, 291–303.
Ricciardolo, F.L.M. (2003) Multiple roles of nitric oxide in the airways. Thorax 58, 175–182.
Clancy, R.M., Leszczynska-Piziak, J. and Abramson, S.B. (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90, 1116–1122.
Beckman, J.S. and Crow, J.P. (1993) Pathological importance of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21, 330–334.
Rodenas, J., Mitjavila, M.T. and Carbonell, T. (1995) Simulataneous generation of nitric oxide and superoxide by inflammatory cells in rats. Free Radic. Biol. Med. 18, 869–875.
Ross, D, Indranil, D., Nathan, J. and Yedy, I. (1998) Effect of antithyroid drugs on hydroxyl radical formation and α-1-proteinase inhibitor inactivation by neutrophils: therapeutic implications. J. Pharm. Exp. Ther. 285, 1233–1238.
Brune, B. and Lapetine, E.G. (1989) Activation of cytosolic ADP-ribosyl transferase by nitric oxide generating agents. J Biol Chem 269, 8455–8461.
Piper, G.M., Clarke, G.A. and Gross, G.J. (1994) Stimulatory and inhibitory action of nitric oxide donor agentsvs nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J Pharmacol. Exp. Ther. 269, 451.
Morikawa, M., Inoue, M., Tokumaru, S. and Kogo, H. (1995) Enhancing and inhibitory effects of nitric oxide on superoxide anion generation in human polymorphonuclear leukocytes. Br J Pharmacol 115, 1303.
Pryor, W.A., Dooley, M.M. and Church, D.F. (1984) Inactivation of human α-1-proteinase inhibitor by gas phase cigarette smoke. Biochim. Biophys. Res. Comm. 122, 676–681.
Fagerhol, M.K. and Cox, D.W. (1981) The Pi polymorphism: Genetic, biochemical and clinical aspects of human α-1-antitrypsin. Adv. Human. Genet. 11, 1–10.
Travis, J. and Salvensen, G.S. (1983) Human plasma proteinase inhibitors. Ann. Rev. Biochem. 52, 655–709.
Beatty, K., Beith, J. and Travis, J. (1980) Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255; 3931–3935.
Arthur, B.Z. (1993) Genetic disease of the pulmonary parenchyma, In: Pulmonary disease (fifth ed.). Eds. Gerald L Baum and Emanuel Wolinsky), Boston: Little, Brown and company, pp 1785–1813.
Khan, A.R., Mir, M.M., Wani, J.I., Siddiqi, M.A. and Salahuddin, M. (1998) Superoxide generation by resting and activated polymorphonuclear leucocytes obtained from smokers and nonsmokers. Med. Sci. Res. 26, 471–473.
Glaser, C.B., Chamorro, M., Crowley, R., Karic, L., Childs, A. and Calderon, M. (1982) The isolation of α-1-proteinase inhibitor by a unique procedure designed for industrial application. Anal. Biochem. 124, 364–371.
Beatty, K., Beith, J. and Travis, J. (1982) Determination of oxidized alpha-1-proteinase inhibitor. J. Lab. Clin. Med. 100, 86–92.
Greenwald, R.A., Scott, W. Rush, S.A.M. and Zee, V.W. (1989) Conversion of superoxide generated by polymorphonuclear leucocytes to hydroxyl radical: A direct spectrophotometric detection system based on degradation of deoxyribose. Free. Radic. Biol. Med. 6, 385–392.
Bennett, B.M., Kobus, S.M., Brien, J.F., Nakatsu, K. and Marks, G.S. (1986) Requirement of reduced, unliganded hemoproteins for the hemoglobin and myoglobin mediated biotransformation of glyceryl trinitrite. J. Pharmacol. Exp. Ther. 237, 629–632.
Babior, B.M., Lambeth, J.D. and Nauseef, W. (2002). The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342–344.
Babior, B.M. (1999) NADPH oxidase: an update. Blood 93, 1464–1476.
Leto, T.L., Garrett, M.C., Fujjii, H. and Nunoi, H. (1991) Characterization of neutrophil NADPH oxidase factor p47phox and p67 phox from recombinant baculoviruses. J. Biol. Chem. 266, 19812–19818.
Hazan, I., Dana, R., Granot, Y. and Levy, R. (1997) Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan, correlation between 42/44 kDa mitogen-activated kinase, cytosolic phospholipase A2 and NADPH oxidase. Biochem. J 326, 867–876.
Hazan, I., Seger, R. and Levy, R. (2000) The requirement of both extracellular regulatd kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A2 activity by either FcγRII Aor FcαRIIIB in human neutrophils. J Biol. Chem. 275, 12416–12423.
Shmelzer, Z., Haddad, N., Admon, E., Pessachh, I., Leto, T.L., Eitan-Hazan, Z., Hershfinkel, M. and Levy, R. (2003) Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by thhe NADPH oxidase in phagocytes. J. Cell Biol. 162, 683–692.
Foubert, T.R., Burritt, J.B., Taylor, R.M. and Jesaitis, A.J. (2000) Structural changes are induced in human neutrophil cytochrome b by NADPH oxidase activators, LDS, SDS, and arachidonate: intermolecular resonance energy transfer between trisulfopyrenyl-wheat germ agglutinin and cytochrome b558. Biochim. Biophys. Acta. 1557, 321–231.
Ueno, N., Murakami, M., Tanioka, T., Fujimori, K., Tanabe, T., Urade, Y. and Kudo, I. (2001) Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J Biol. Chem. 276, 34918–34927
Tuluc, F., Garcia, A., Bredetean, O., Meshki, J. and Kunapuli S.P. (2004) Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways. Am. J. Physiol. Cell Physiol. 287, 1264–1272.
Crossley, L.J. (2003) Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1. J. Leukoc. Biol. 74, 583–592.
Jacob, C., Szilagyi, C., Allen, J.M., Bertrand, C. and Lagente, V. (2004) Role of PDE4 in superoxide anion generation through p44/42 MAPK regulation: a cAMP and a PKA-independent mechanism, Br. J. Pharmacol. 143, 257–268.
Walters, J.D. and Nakkula, R.J. (2003) Ciprofloxacin transport by chemoattractant-activated polymorphonuclear leukocytes: regulation by priming and protein kinase C. Antimicrob. Agents Chemother. 47, 3345–3348.
Fujita, T., Zawawi, K.H., Kurihara, H. and Van Dyke, T.E. (2005) CD38 cleavage in fMLP- and IL-8-induced chemotaxis is dependent on p38 MAP kinase but independent of p44/42 MAP kinase. Cell Signal. 17, 167–75 (Medline).
Halliwell, B., Gutteridge, J.M.C. and Blake, D.R. (1985) Metal ion and oxygen radical reaction in human inflammatory joint disease. Phil. Trans. R. Soc. 311, 659–671.
Aruoma, O.I., Halliwell, B. and Dizdaroglu, M. (1991) Copper ion dependent damage to the bases in DNA in presence of hydrogen peroxide. Biochem. J. 273, 601–604.
Ambruso, D.R. and Johnson Jr., R.B. (1981) Lactoferin enhances hydroxyl radical production by human neurtophil, neutrophil particulate fractions and an enzyme generating system. J. Clin. Invest. 67, 352–360.
Palmer, R.M.J., Ferrige, A.G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelial derived relaxing factor. Nature 327; 524–527.
Kubes, P., Suzuki, M. and Granger, D.N. (1991), Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc. Natl. Acad. Sci. (USA). 88, 4651–4655.
Mulligam, M.S., Hevel, J.M., Marletta, M.A. and Ward, P.A. (1991) Tissue injury caused by deposition of immune complexes is L-Arg dependent. Proc. Natl. Acad. Sci. (USA) 88, 6338–6341.
Rubanyi, G.M., Ho, E.H., Cantor, E.H., Lumma, W.C. and Botelhi, L.H.P. (1991) Cytoprotective function of nitric oxide. Inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181, 1392–1395.
Peterson, D.A. (1992) The non-specificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187, 797–800.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mir, M.M., Khan, A.R., Dar, N.A. et al. Polymorphonuclear leukocyte mediated oxidative inactivation of alpha-1-proteinase inhibitor: Modulation by nitric oxide. Indian J Clin Biochem 20, 184–192 (2005). https://doi.org/10.1007/BF02893068
Issue Date:
DOI: https://doi.org/10.1007/BF02893068